Butyrophilins Role in Colon Cancer

Recruiting · NCT04185272 · Interventional (participants receive a specific treatment) · Lead sponsor: Institut Paoli-Calmettes

Interventions studied

analysis of BTN and BTNL status

quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer

Age range

18 Years and older

Sex

All (male and female)

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not applicable (e.g. observational or device study)

Study type

Interventional (participants receive a specific treatment)

Patient is older than 18 years old,
Signed participation consent,
Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation meeting.
Performance Status (PS) 0 or 1
affiliated to the social security or beneficiary

Rectal cancer, colon cancer recurrence
Emergency of colon cancer Surgery
History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis)
Patient who received neoadjuvant therapy other than chemotherapy
Patient treated with immune-suppressors or long-course corticosteroids \<12 months
Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding,
Person in urgent situation, person under legal protection measure, or unable to express his / her consent,
Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons

1 location listed.